Toggle navigation
Works
People
Organizations
Repositories
Pages
About
Statistics
Support
Sign In
Loading...
Loading...
A matching-adjusted indirect comparison of acalabrutinib versus zanubrutinib in relapsed or refractory chronic lymphocytic leukemia
https://doi.org/10.6084/m9.figshare.24250873
Loading...
Download Metadata
Cite as
APA
Harvard
MLA
Vancouver
Chicago
IEEE
Download Reports
Related Works (CSV)
Share
Email
Twitter
Facebook
Description
Creators
Registration
Video abstract for our matching-adjusted indirect comparison of acalabrutinib versus zanubrutinib in relapsed or refractory chronic lymphocytic leukemia
Adam S. Kittai
Alan Skarbnik
Miguel Miranda
Alan Yong
Jack Roos
Robert Hettle
Sarah Palazuelos-Munoz
Vikram Shetty
Paolo Ghia
DOI registered
October 10, 2023
via DataCite
Media published 2023 in
figshare Academic Research System
Audiovisual